• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Douglas Davenport

A MEMORY GIANT’S AI-POWERED REAWAKENING

Mad Hedge AI

(MU), (NVDA)

 

When it comes to technology, even the giants can be caught off guard.

Amid the backdrop of an AI boom, certain traditional tech sectors—like general-purpose servers, PCs, and smartphones—have seen their glow dim, with sales rhythms more reminiscent of a slow waltz than the exuberant cha-cha of yesteryears. The lingering specter of our recent pandemic and mounting interest rates have cast these gadgets into the shade.

Yet, even as AI dominates the tech discourse, several dark horses remain on the fringes, overlooked but ready for their moment in the sun. One such name is Micron Technology (MU). 

Micron Technology's year was punctuated with challenges that harked back to 2008's memory slump. In the tech realm, memory behaves much like oil in the global market—standardized and swaying to the whims of supply and demand. The major players in the DRAM game have recalibrated their tactics, paring down production by a notable third.

As a result, this memory chip company faced a storm, reeling from a severe downturn, its worst since the 2008 fiasco. The waning appeal of PCs post-pandemic, the erratic behavior of smartphones, and server shipments gasping for breath collectively strained the demand for dynamic random-access memory (DRAM) and NAND chips, upsetting the equilibrium of supply.

Adding fuel to the fire, China's Cyberspace Administration took a combative stance, barring its domestic infrastructures from procuring Micron's chips. 

By June's close, Micron's quarterly report showed a sobering reality—a 57% YoY drop in revenue, wrapping up June 1. But hope wasn't entirely lost. 

A marginal sequential improvement hinted at a demand, albeit slow, awakening from its stupor. Price dynamics, however, painted a less optimistic narrative, with DRAM's average costs receding 10% quarter-on-quarter and NAND's dipping into the mid-teens.

Embracing the collective industry sentiment, Micron turned judicious, reining production and pruning its capital expenditure. The revised playbook witnessed a 30% cut in DRAM and NAND chip production starts—a trend projected to hold sway into 2024. The fiscal 2023 capex? It saw a stark 40% reduction from its previous year.

But herein lies Micron's masterstroke, reminiscent of a Houdini act—retraction in production and expenditure, executed just as the tech plot seems poised for a twist. 

While conventional PCs and smartphones may have reached their zenith, memory prices—historically—are a roller-coaster, even in stable times. The global pandemic, however, threw in a wild card, sending prices soaring as demand swirled unpredictably.

This is where AI comes in. 

The AI server domain, by all accounts, is primed for explosive growth. Projections chart a trajectory from $30 billion to a whopping $150 billion by 2027, effectively mirroring the trajectory of our standard server market. 

The implications for Micron? AI servers are voracious for DRAM and NAND, demanding 6-8 times and thrice the amount, respectively, compared to their generic counterparts.

NVIDIA (NVDA), AI's reigning monarch, has unveiled its H100 data-center GPU—an engineering marvel equipped with 188GB of high bandwidth memory 3 (HBM3). Fast and efficient, it's poised to be AI processing's poster child. 

Experts are hedging their bets on HBM3 and DDR5 memory to revitalize the DRAM market. And if these projections crystallize, the third quarter could mark a watershed moment.

Although a latecomer to the HBM fest, Micron made a dramatic entry in July, parading its HBM3 chips, promising a 50% bandwidth elevation over existing titans. With the horizon of 2024, Micron's ledger might see a healthy inflow from this endeavor.

The overarching narrative? 

Analysts now anticipate that by 2024, Micron might not just match but potentially overshadow rivals like SK Hynix and Samsung. When it teased the industry with its HBM3 chip—24GB across eight layers, boasting over 1.2 TB/s, it easily outclassed SK Hynix's version.

Yet, Micron's portfolio isn't merely confined to HBM. They pulled ahead of their competition in the non-AI memory segment in 2022, unveiling the 232-layer NAND flash and 1-beta DRAM. This prowess insulated Micron during industry lows.

Micron's trajectory in the face of adversity mirrors the greater ebb and flow of the memory market. Like a roller coaster, fortunes rise and plunge with dizzying rapidity. This downturn was undeniably steep, propelling dominant players to adopt austerity measures. Yet, the insatiable hunger of AI for memory hints at an impending surge.

In its relentless march, artificial intelligence has a unique way of rejuvenating dormant giants. Micron's recent technological leaps set it apart. As the world stands at the cusp of another AI-driven metamorphosis, Micron emerges as the stock to watch, encapsulating the very essence of the industry's capacity for renewal and resurgence.

Midjourney prompt: “Waking the sleeping AI giant”

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/09/Screenshot-2023-09-08-c2.png 591 882 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2023-09-08 16:04:562023-09-08 16:04:56A MEMORY GIANT’S AI-POWERED REAWAKENING
april@madhedgefundtrader.com

September 8, 2023

Tech Letter

Mad Hedge Technology Letter
September 8, 2023
Fiat Lux

Featured Trade:

(THE SUSHI HITS THE FAN IN CUPERTINO)
(APPL), (MCHI),

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 15:03:372023-09-08 15:34:11September 8, 2023
april@madhedgefundtrader.com

The Sushi Hits the Fan in Cupertino

Tech Letter

When it rains – it pours. Let’s talk about China (MCHI) and Apple (AAPL) CEO Tim Cook.

I admit that I was quite harsh on Tim Cook 7 years ago when writing this Mad Hedge Technology letter.

I routinely delivered scathing critiques of him and perpetuated the narrative that he was only an operations guy.

Then I lightened up as he drove the company to higher highs even though the company didn’t foray too far from its bread and butter the iPhone. 

My fierce criticism revolved around Cook betting the ranch on an Eastern adversary at a time when deglobalization started to pick up pace.

After knocking out the $2 trillion market cap and vaulting past $3 trillion, I gave Cook a pass for the time being.

Fast forward 7 years and the sushi has hit the fan and Cook has an absolute fiasco on his hands.

The trouble brewing in China is not necessarily entirely his fault, but sleep with the enemy, and it is hard to whine about the consequences.

In one fell swoop, 60 million hardcore Apple customers are dropping Apple products.

It’s a swift kick in the nuts for Cook.

Funnily enough, just a few months ago, Tim Cook was one of the few U.S. CEOs to venture to China after its reopening with his usual kowtowing to the communist party.

In March, he declared that Apple and China had a “symbiotic kind of relationship.”

It is bizarre to hear such an important figure in the American technology apparatus so infatuated with the Chinese.

Beijing is ordering officials in all departments to stop using iPhones.

Then Beijing extended the ban to state-owned enterprises.

How important is China to Apple?

China is key to Apple’s supply chain and to its sales.

About half of Apple’s smartphones are made in a giant factory complex in Zhengzhou, nicknamed “iPhone City”, operated by electronics manufacturer Foxconn.

China is also a significant consumer market for Apple, as it is the largest market outside the U.S. The company generated $15.8 billion in sales from China alone last quarter, 20% of its total.

Chinese consumers gravitate to the iPhone too: Apple has 65% market share for premium phones over $600.

There is a big element here in getting Chinese people to use their own smartphones.

I know many people who use Chinese smartphones because they are flagship quality but 40% cheaper than iPhones.

The only piece lacking is usually the Apple quality high-end camera, but most people don’t use their phone for a high-definition YouTube channel.

My sense is that the 60 million white-collar Chinese people will grumble about the brand downgrade to Huawei or Xiaomi, but the drop-off in performance isn’t so crazy that they are willing to go rogue and find a roundabout way to use an iPhone.

This sets the stage for all Apple products to get banned full-stop in China which is 20% of Apple’s revenue.

That includes Apple watches, earbuds, computers, and the whole shebang even the services part of the equation.

Deglobalization is rearing its ugly head again and this event could be a catalyst to take Apple shares back down to more affordable levels.

I would look at buying the dip once this negative news works itself through the system.

However, this event is akin to the tech sector getting stunned with a left hook to its face, and it will take time to recover don’t expect any American corporations to do business in China anytime soon under these souring conditions.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 15:02:392023-09-08 16:39:50The Sushi Hits the Fan in Cupertino
april@madhedgefundtrader.com

September 8, 2023 - Quote of the Day

Tech Letter

“The art of living is more like wrestling than dancing.” – Said Roman Leader Marcus Aurelius

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 15:01:352023-09-08 15:32:28September 8, 2023 - Quote of the Day
april@madhedgefundtrader.com

September 8, 2023

Jacque's Post

 

(MARKET MOVEMENTS CAN BE UNDERSTOOD WITH THIS METHOD)

September 8, 2023

 

Hello everyone,

We have all heard of technical analysis and how it can fine-tune our entries into and exits out of trades.

I’m sure many of you have heard of moving averages, (RSI) Relative Strength Index, (MACD) Moving Average Convergence Divergence, Fibonacci, Elliott Wave theory, and Stochastics. 

But have you ever heard of the Wyckoff Method?

What is the Wyckoff Method?

The Wyckoff Method is a technical analysis approach to the markets that investors can use to decide when to buy and sell.  The Wyckoff market cycle reflects Wyckoff’s theory of what drives a stock’s price movement.  The method is based on the premise that stocks and markets move in predictable cycles.  Wyckoff identified nine primary cycles, each of which has a characteristic pattern of price movement.  The approach is relatively simple:  when well-informed traders want to buy or sell, they carry out processes that leave their traces on the chart through price and volume.

There are four phases of a Wyckoff market cycle: accumulation, markup, distribution, and markdown.

 

 

At the top of the markup phase, another event is expected to happen – the Wyckoff distribution phase where the buying pressure ends, and smart traders take their profits and close their positions.

The Wyckoff Method is based on three laws:  the law of Supply and Demand, the law of Cause and Effect, and the law of Effort vs. Result.

The Law of Supply and Demand states that the price of a stock is determined by the balance between the supply of shares available for purchase and the demand for those shares.  When demand for a stock is high, the price will rise, and when supply is high and demand is low, the price will fall.

The Law of Cause-and-Effect states that every price move has a cause, whether it is a fundamental development or market speculation.  By identifying the cause of a price move, traders can better understand the likely direction of future price movements.

The Law of Effort vs Result states that the market moves in trends and that these trends are characterised by periods of accumulation, markup, distribution, and markdown.  The effort, or the amount of buying or selling pressure, and the result, or the price movement, can be used to identify the stage of the trend and make informed trading decisions.

 

 

The Wyckoff Method was developed by Richard Wyckoff (1873-1934).  It consists of a series of principles and strategies initially designed for traders and investors and can be applied to all financial markets.

Wyckoff started as a stockbroker at the age of 15 and by the age of 25 he already owned his own brokerage firm.

 

 

Through his observation, while working as a broker Wyckoff noticed the manipulations the big operators carried out and with which they obtained high profits.

He stated that “it was possible to judge the future course of the market by its own actions since the price action reflects the plans and purposes of those who dominated it.”

 

 

Enjoy your weekend.

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 11:00:122023-09-08 11:27:39September 8, 2023
april@madhedgefundtrader.com

September 8, 2023

Diary, Newsletter, Summary

Global Market Comments
September 8, 2023
Fiat Lux

Featured Trade:

(THE MAD HEDGE TRADER’S AND INVESTORS SUMMIT IS ON!)
(HOW TO AVOID THE PONZI SCHEME TRAP)
(TESTIMONIAL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 09:08:182023-09-08 08:58:12September 8, 2023
april@madhedgefundtrader.com

The Mad Hedge September Traders & Investors Summit is On!

Diary, Newsletter

The Fed has stopped raising interest rates, inflation is falling, and tech stocks are about to catch fire!

What should you do about it?

Attend the Mad Hedge Traders & Investors Summit from September 12-13. Learn from 15 of the best professionals in the market with decades of experience and the track records to prove it. Every strategy and asset class will be covered, including stocks, bonds, foreign exchange, precious metals, commodities, energy, and real estate.

Best of all, by signing up you will automatically have a chance to win up to $66,000 in prizes.

Usually, access to an exclusive conference like this costs thousands of dollars. You can attend for free!

Listening to this webinar will change your life! To register, please click here.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-08 09:06:142023-09-13 09:56:44The Mad Hedge September Traders & Investors Summit is On!
april@madhedgefundtrader.com

September 7, 2023

Biotech Letter

Mad Hedge Biotech and Healthcare Letter

September 7, 2023

Fiat Lux

Featured Trade:

(SUGAR, SPICE, AND EVERYTHING NICE)

(NVO), (LLY), (MRK), (JNJ), (AZN), (LVMH)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-07 17:02:532023-09-07 18:12:27September 7, 2023
april@madhedgefundtrader.com

Sugar, Spice, and Everything Nice

Biotech Letter

If the weight-loss drug market is a tide, Novo Nordisk (NVO) stands at its crest. As investors, when we seek promising ventures, we look for history, market presence, and future potential–and this Danish pharmaceutical powerhouse seems to tick all these boxes.

Dive into the annals of Novo Nordisk's story, and you'll find a century-old legacy predominantly immersed in diabetes treatment. This enterprise, with Eli Lilly (LLY) and Sanofi (SNY), once commanded an impressive 90% insulin market share.

But things changed when Sanofi made its exit in 2019, setting the stage for Novo Nordisk's next significant act. Though others such as Merck (MRK), Johnson & Johnson (JNJ), and AstraZeneca (AZN) are present in the diabetes space, they operate in unique niches, focusing primarily on small molecules.

So, what is Novo Nordisk's contemporary claim to fame? It’s none other than the weight-loss drug, Wegovy.

As of its recent U.K. debut, Wegovy is now associated with the National Health Service. This was a strategic move that saw the company's value soar, comfortably eclipsing the luxury behemoth Louis Vuitton (LVMH).

The numbers speak for themselves: Novo Nordisk's stock surged 40% this year, pushing its market cap to an enviable $428 billion.

If they were based stateside, this positions them as the 14th most valuable entity in the S&P 500.

What's truly jaw-dropping is the scale of Novo Nordisk's success. It achieved European market leadership with Wegovy's debut in just five significant markets: Denmark, Norway, Germany, the U.S., and the U.K. The demand seems to be exploding every time the drug lands in a new market.

Meanwhile, their main competitor, Eli Lilly, isn't actually that far behind. Bolstered by their Mounjaro drug, they've seen a stock uptick of 52% this year.

Novo Nordisk's current revenue is approximately $26 billion, predominantly from its diabetes drugs lineup. However, by 2030, forecasts predict the obesity market could range from $30 billion to even $100 billion.

And only a few major players are in line to capitalize on this. Notably, Novo Nordisk and Eli Lilly are poised to dominate this space, with a combined projected market share of 82%.

Furthermore, whispers in the pharmaceutical sector suggest that Novo's golden molecule, semaglutide, has broader applications. Beyond diabetes and obesity, it might target three substantial markets in the coming decade.

Firstly, the cardiovascular space, valued at $162 billion in 2022, presents significant potential. Early indications reveal that semaglutide might offer protective benefits against cardiovascular threats. If Novo gains the necessary approvals, its market share could rise substantially.

Secondly, non-alcoholic steatohepatitis (NASH) affects nearly 30 million Americans. Market evaluations for this condition vary, with some projections reaching $62 billion by 2031.

Novo Nordisk is already deep into phase 3 clinical trials, and if semaglutide proves effective here, it would be another feather in the company's cap.

Lastly, the treatment of addiction disorders could be an untapped market for semaglutide. Preliminary research shows promise, but real-world human trials are still in their infancy. If validated, this could open another revenue stream for Novo Nordisk in the years to come.

Overall, Novo Nordisk is more than just a pharmaceutical company; it's a saga of consistent growth, innovation, and potential.

If you had invested in its shares between 2017 and 2019, today's valuation would offer substantial returns.

Admittedly, the current valuation is on the higher side. Still, context matters.

In light of the above, my advice is two-fold. For those eyeing short-term gains, a 'Hold' might be the best strategy for Novo Nordisk. But if you're in it for the long haul, with a decade or more in view, this is a definitive 'Buy.'

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-07 17:00:242023-09-07 18:11:58Sugar, Spice, and Everything Nice
april@madhedgefundtrader.com

September 7, 2023

Diary, Newsletter, Summary

Global Market Comments
September 7, 2023
Fiat Lux

Featured Trade:

(The Mad Hedge September Traders & Investors Summit is ON!)
(THE LONG VIEW ON EMERGING MARKETS),
(TESTIMONIAL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-09-07 09:08:152023-09-07 12:10:15September 7, 2023
Page 11 of 14«‹910111213›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top